Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Michael Levy, MD, PhD
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Le Hua, MD
Modern MS Management: Leveraging Technology to Support Brain Health
Victoria Leavitt, PhD
Gates B. Colbert, MD
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Marc Haut, PhD
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Christoph U. Correll, MD
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Reevaluating Spinal Muscular Atrophy Therapy: Signs, Tools, and Strategies
Brian P. McDonough, MD, FAAFP
Nancy Kuntz, MD
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.